首页> Frontiers in medicine> Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma.

Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christian,Ihling

第一单位： Global Clinical Biomarkers & Companion Diagnostics, Merck KGaA, Darmstadt, Germany.

作者： Christian,Ihling ^[1] ; Bartholomew,Naughton ^[2] ; Yue,Zhang ^[3] ; P Alexander,Rolfe ^[2] ; Eveline,Frick-Krieger ^[1] ; Luigi M,Terracciano ^[4] ; Isabelle,Dussault ^[3]

作者单位： Global Clinical Biomarkers & Companion Diagnostics, Merck KGaA, Darmstadt, Germany. ^[1] Quantitative Pharmacology and Drug Disposition, EMD Serono, Inc., Billerica, MA, United States. ^[2] Clinical Biomarkers & Companion Diagnostics Biopharma, EMD Serono, Inc., Billerica, MA, United States. ^[3] Molecular Pathology Division, Institute of Pathology, University Hospital, Basel, Switzerland. ^[4]

关键词 CD8 HCC PD-L1 checkpoint inhibitor hepatocellular carcinoma immune cell infiltrates

DOI 10.3389/fmed.2019.00015

PMID 30800658

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览17

Frontiers in medicine

2019年6卷

15页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览17

Frontiers in medicine

2019年6卷

15页

检索历史清除

Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma.

Frontiers in medicine

相似文献

同项目论文

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma.

Frontiers in medicine

相似文献

同项目论文

Frontiers in medicine

相关期刊

检索历史清除